<i>SLFN11</i> Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
Sai-Wen Tang(National Institutes of Health), Yves Pommier(National Cancer Institute), Mihoko Yamade(Hamamatsu University School of Medicine), Javed Khan(Kent State University), Paul S. Meltzer(National Cancer Institute), Liang Cao(National Institutes of Health), Sven Bilke(Illumina (United States)), Fabrício G. Sousa(Universidade Federal de Mato Grosso do Sul), Lee J. Helman(American Osteopathic Association), Sudhir Varma, Junko Murai(Ehime University), Vinodh N. Rajapakse(National Cancer Institute)
Cited by 103
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711